173 related articles for article (PubMed ID: 19788771)
1. Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients.
Shinn EH; Taylor CL; Kilgore K; Valentine A; Bodurka DC; Kavanagh J; Sood A; Li Y; Basen-Engquist K
Palliat Support Care; 2009 Sep; 7(3):299-306. PubMed ID: 19788771
[TBL] [Abstract][Full Text] [Related]
2. Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers.
Manne SL; Myers-Virtue S; Kissane D; Ozga ML; Kashy DA; Rubin SC; Rosenblum NG; Heckman CJ
Psychooncology; 2017 Nov; 26(11):1799-1809. PubMed ID: 27421919
[TBL] [Abstract][Full Text] [Related]
3. Hopelessness and complementary therapy use in patients with ovarian cancer.
Gross AH; Cromwell J; Fonteyn M; Matulonis UA; Hayman LL
Cancer Nurs; 2013; 36(4):256-64. PubMed ID: 23086133
[TBL] [Abstract][Full Text] [Related]
4. Canadian women's perspectives on ovarian cancer.
Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of ovarian cancer and fear of recurrence.
Ozga M; Aghajanian C; Myers-Virtue S; McDonnell G; Jhanwar S; Hichenberg S; Sulimanoff I
Palliat Support Care; 2015 Dec; 13(6):1771-80. PubMed ID: 25728373
[TBL] [Abstract][Full Text] [Related]
6. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
7. Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
Wen Q; Shao Z; Zhang P; Zhu T; Li D; Wang S
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():85-91. PubMed ID: 28738296
[TBL] [Abstract][Full Text] [Related]
8. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
9. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer.
Frey MK; Ellis AE; Zeligs K; Chapman-Davis E; Thomas C; Christos PJ; Kolev V; Prasad-Hayes M; Cohen S; Holcomb K; Blank SV
Am J Obstet Gynecol; 2020 Nov; 223(5):725.e1-725.e9. PubMed ID: 32598911
[TBL] [Abstract][Full Text] [Related]
10. Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.
Lutgendorf SK; Shinn E; Carter J; Leighton S; Baggerly K; Guindani M; Fellman B; Matzo M; Slavich GM; Goodman MT; Tew W; Lester J; Moore KM; Karlan BY; Levine DA; Sood AK
Gynecol Oncol; 2017 Jul; 146(1):101-108. PubMed ID: 28527672
[TBL] [Abstract][Full Text] [Related]
11. Sword of Damocles cutting through the life stages of women with ovarian cancer.
Cesario SK; Nelson LS; Broxson A; Cesario AL
Oncol Nurs Forum; 2010 Sep; 37(5):609-17. PubMed ID: 20797952
[TBL] [Abstract][Full Text] [Related]
12. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.
Brown AJ; Sun CC; Urbauer DL; Bodurka DC; Thaker PH; Ramondetta LM
Gynecol Oncol; 2015 Aug; 138(2):388-93. PubMed ID: 25988961
[TBL] [Abstract][Full Text] [Related]
13. Optimism, social support, and mental health outcomes in patients with advanced cancer.
Applebaum AJ; Stein EM; Lord-Bessen J; Pessin H; Rosenfeld B; Breitbart W
Psychooncology; 2014 Mar; 23(3):299-306. PubMed ID: 24123339
[TBL] [Abstract][Full Text] [Related]
14. Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?
Price MA; Butow PN; Bell ML; deFazio A; Friedlander M; Fardell JE; Protani MM; Webb PM;
Support Care Cancer; 2016 Jun; 24(6):2627-34. PubMed ID: 26732767
[TBL] [Abstract][Full Text] [Related]
15. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study.
van den Beuken-van Everdingen MH; Peters ML; de Rijke JM; Schouten HC; van Kleef M; Patijn J
Psychooncology; 2008 Nov; 17(11):1137-45. PubMed ID: 18484568
[TBL] [Abstract][Full Text] [Related]
16. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation.
Thiele S; Goebel S; Kröger N; Pedersen A
Psychooncology; 2020 Aug; 29(8):1248-1254. PubMed ID: 32323380
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in ovarian cancer patients receiving chemotherapy.
Lakusta CM; Atkinson MJ; Robinson JW; Nation J; Taenzer PA; Campo MG
Gynecol Oncol; 2001 Jun; 81(3):490-5. PubMed ID: 11371144
[TBL] [Abstract][Full Text] [Related]
18. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study.
Wenzel LB; Donnelly JP; Fowler JM; Habbal R; Taylor TH; Aziz N; Cella D
Psychooncology; 2002; 11(2):142-53. PubMed ID: 11921330
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment.
Srisuttayasathien M; Khemapech N
Asian Pac J Cancer Prev; 2013; 14(12):7669-74. PubMed ID: 24460351
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
Mirabeau-Beale KL; Kornblith AB; Penson RT; Lee H; Goodman A; Campos SM; Duska L; Pereira L; Bryan J; Matulonis UA
Gynecol Oncol; 2009 Aug; 114(2):353-9. PubMed ID: 19481244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
